- Home
- HSIC vs RVMD Comparison
HSIC vs RVMD Comparison
Compare HSIC & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSIC
- RVMD
- Stock Information
- Founded
- HSIC 1932
- RVMD 2014
- Country
- HSIC United States
- RVMD United States
- Employees
- HSIC N/A
- RVMD N/A
- Industry
- HSIC Medical Specialities
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HSIC Health Care
- RVMD Health Care
- Exchange
- HSIC Nasdaq
- RVMD Nasdaq
- Market Cap
- HSIC 9.0B
- RVMD 7.5B
- IPO Year
- HSIC 1995
- RVMD 2020
- Fundamental
- Price
- HSIC $70.64
- RVMD $37.81
- Analyst Decision
- HSIC Buy
- RVMD Strong Buy
- Analyst Count
- HSIC 10
- RVMD 13
- Target Price
- HSIC $78.70
- RVMD $68.38
- AVG Volume (30 Days)
- HSIC 1.7M
- RVMD 3.3M
- Earning Date
- HSIC 08-05-2025
- RVMD 08-06-2025
- Dividend Yield
- HSIC N/A
- RVMD N/A
- EPS Growth
- HSIC 8.11
- RVMD N/A
- EPS
- HSIC 3.21
- RVMD N/A
- Revenue
- HSIC $12,669,000,000.00
- RVMD N/A
- Revenue This Year
- HSIC $4.28
- RVMD N/A
- Revenue Next Year
- HSIC $3.57
- RVMD $226.82
- P/E Ratio
- HSIC $22.12
- RVMD N/A
- Revenue Growth
- HSIC 1.75
- RVMD N/A
- 52 Week Low
- HSIC $60.56
- RVMD $29.17
- 52 Week High
- HSIC $82.49
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- HSIC 40.66
- RVMD 46.33
- Support Level
- HSIC $69.04
- RVMD $36.37
- Resistance Level
- HSIC $75.76
- RVMD $38.97
- Average True Range (ATR)
- HSIC 1.52
- RVMD 1.34
- MACD
- HSIC -0.39
- RVMD 0.07
- Stochastic Oscillator
- HSIC 23.81
- RVMD 37.26
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.